Overall rank by patents
#48,902
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 13 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A44C (PERSONAL ADORNMENTS, e.g. JEWELLERY; COINS).
The verdict
Monnaie holds 5 US patents across 13 technology areas, rank #48,902 of 50,000 tracked assignees.
Monnaie Royale Canadienne/royal Canadian Mint has been granted 5 US utility patents between 2017 and 2025, placing Monnaie Royale Canadienne/royal Canadian Mint at rank #48,902 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in A44C (PERSONAL ADORNMENTS, e.g. JEWELLERY; COINS). As a Foreign Corporation, Monnaie Royale Canadienne/royal Canadian Mint is one of the more focused assignees in the PatentsView dataset. By volume, Monnaie sits between Molecular Health Gmbh (5 patents, rank #48,898) and Moog Wolverhampton Limited (5 patents, rank #48,906) - the closest US assignees by grant volume. The composite Innovation Score of 31.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 2 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Monnaie Royale Canadienne/royal Canadian Mint's 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Monnaie Royale Canadienne/royal Canadian Mint against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Molecular Health GmbH
5 patents
Molecure S.A.
5 patents
Moncler S.P.A.
5 patents
Moneyhun Equipment Sales & Service Co., Inc.
5 patents
Monolythix, Inc.
5 patents
Monos Travel Ltd.
5 patents
Montres Rado SA
5 patents
Moog Wolverhampton Limited
5 patents
Monnaie Royale Canadienne/Royal Canadian Mint
5 patents
What this shows Monnaie holds 5 patents at rank #48,902, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #48,902 in granted patent volume.
Other assignees with the most granted patents in Monnaie's primary technology class.
Monnaie's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 62% higher than 38% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
| 2025 | 1 | 20.0% |
Top 13 of 13 technology areas
Overall rank by patents
#48,902
Across all tracked assignees
31.6 out of 100
How to use this portfolio
Monnaie's 5 grants land it in the top 62% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.